Seek Returns

MEDP vs. RDY: Medpace vs. Dr. Reddy's Laboratories Stock Comparison

How do Medpace (MEDP) and Dr. Reddy's Laboratories (RDY) stack up? This page sets them side by side across company profile, performance and risk, profitability, growth, financial strength, dividends, and valuation, with selected fundamentals also measured against each stock's industry-group peers.

Company Profile

Medpace (MEDP) and Dr. Reddy's Laboratories (RDY) both fall under the Pharmaceuticals, Biotechnology & Life Sciences industry group, but MEDP is classified in Life Sciences Tools & Services while RDY is classified in Pharmaceuticals.

Medpace (MEDP) trades as ordinary local shares, while Dr. Reddy's Laboratories (RDY) trades as an ADR — compare with FX exposure, depositary-program fees, and dividend-withholding-tax differences in mind.

Company profile comparison for Medpace (MEDP) and Dr. Reddy's Laboratories (RDY)
Profile ItemMEDPRDY
NameMedpace Holdings, Inc.Dr. Reddy's Laboratories Ltd. ADR
Country/RegionUnited StatesIndia
GICS SectorHealth CareHealth Care
GICS Industry GroupPharmaceuticals, Biotechnology & Life SciencesPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & ServicesPharmaceuticals
GICS Sub-IndustryLife Sciences Tools & ServicesPharmaceuticals
Market Capitalization18.27 billion USD12.43 billion USD
CurrencyUSDUSD
ExchangeNasdaqNYSE
Listing DateAugust 11, 2016April 11, 2001
Security TypeCommon StockADR

Price Performance

Cumulative Growth

MEDP
RDY
GSPC
Loading price history…
Medpace (MEDP) vs. Dr. Reddy's Laboratories (RDY), with S&P 500 (GSPC) for reference: Growth of a $10,000 investment over the past five years. Adjusted for dividends and splits.

Trailing Returns

Loading price history…
Trailing total returns for Medpace (MEDP) and Dr. Reddy's Laboratories (RDY). Returns over one year are annualized.

Calendar-Year Returns

Loading price history…
Calendar-year total returns for Medpace (MEDP) and Dr. Reddy's Laboratories (RDY). Each bar is that year's total return, measured year-end to year-end.

Performance Metrics

Price performance metrics for Medpace (MEDP) and Dr. Reddy's Laboratories (RDY)
MetricMEDPRDY
Total Return (1Y)13.29%12.49%
Total Return (3Y, Annualized)35.26%5.76%
Total Return (5Y, Annualized)24.49%4.06%

Risk Profile

Drawdown History

MEDP
RDY
GSPC
Loading price history…
Medpace (MEDP) vs. Dr. Reddy's Laboratories (RDY), with S&P 500 (GSPC) for reference: Drawdown from the running peak over the past five years. Each line shows the decline from its prior peak; 0% marks a new high.

Return Distribution

Loading price history…
Distribution of monthly total returns for Medpace (MEDP) and Dr. Reddy's Laboratories (RDY). Each bar is the share of months whose return fell in that 5% bucket.

Risk Metrics

Risk profile metrics for Medpace (MEDP) and Dr. Reddy's Laboratories (RDY)
MetricMEDPRDY
Volatility (1Y, Annualized)44.16%27.06%
Beta (5Y)1.100.30
Max Drawdown (5Y)-42.87%-32.01%
Avg. Volume (3M)258.39K2.89M

Risk-Adjusted Performance

Risk-Return Positioning

Loading chart…
MEDP and RDY are plotted by 1-year volatility (risk) and 1-year return. The dashed Capital Allocation Line runs from the risk-free rate through the shared industry median.

Risk-Adjusted Metrics

Risk-adjusted metrics for Medpace (MEDP) and Dr. Reddy's Laboratories (RDY)
MetricMEDPRDY
Sharpe Ratio (1Y)0.200.30
Sortino Ratio (1Y)0.260.43

Profitability

ROE (TTM)

Both companies show strong equity returns, but Medpace (MEDP) at 117.88% is the standout with ROE above its industry range; Dr. Reddy's Laboratories (RDY) at 7.34% also sits in the top quartile.

MEDP

Pharmaceuticals, Biotechnology & Life Sciences industry group

117.88%

MEDP
117.88%
Max
109.18%
Q3
6.23%
Median
-26.66%
Q1
-64.05%
Min
-167.77%

RDY

Pharmaceuticals, Biotechnology & Life Sciences industry group

7.34%

Max
109.18%
RDY
7.34%
Q3
6.23%
Median
-26.66%
Q1
-64.05%
Min
-167.77%
Loading chart…
Medpace (MEDP) vs. Dr. Reddy's Laboratories (RDY): A comparison of their ROE against the Pharmaceuticals, Biotechnology & Life Sciences industry group benchmark.

Net Margin (TTM)

Medpace (MEDP) at 18.24% keeps the most of each sales dollar — above its industry’s net margin range — and Dr. Reddy's Laboratories (RDY) at 8.49% also retains a top-quartile share.

MEDP

Pharmaceuticals, Biotechnology & Life Sciences industry group

18.24%

MEDP
18.24%
Max
18.05%
Q3
4.78%
Median
0.00%
Q1
-4.14%
Min
-17.05%

RDY

Pharmaceuticals, Biotechnology & Life Sciences industry group

8.49%

Max
18.05%
RDY
8.49%
Q3
4.78%
Median
0.00%
Q1
-4.14%
Min
-17.05%
Loading chart…
Medpace (MEDP) vs. Dr. Reddy's Laboratories (RDY): A comparison of their net margin against the Pharmaceuticals, Biotechnology & Life Sciences industry group benchmark.

Operating Margin (TTM)

Medpace (MEDP) at 23.12% operates in the top operating margin quartile, ahead of Dr. Reddy's Laboratories (RDY) at 14.73%, which runs around its industry’s norm.

MEDP

Pharmaceuticals, Biotechnology & Life Sciences industry group

23.12%

Max
83.12%
MEDP
23.12%
Q3
14.77%
Median
0.00%
Q1
-78.82%
Min
-207.40%

RDY

Pharmaceuticals, Biotechnology & Life Sciences industry group

14.73%

Max
83.12%
Q3
14.77%
RDY
14.73%
Median
0.00%
Q1
-78.82%
Min
-207.40%
Loading chart…
Medpace (MEDP) vs. Dr. Reddy's Laboratories (RDY): A comparison of their operating margin against the Pharmaceuticals, Biotechnology & Life Sciences industry group benchmark.

Profitability Metrics

Profitability metrics for Medpace (MEDP) and Dr. Reddy's Laboratories (RDY)
MetricMEDPRDY
ROE (TTM)117.88%7.34%
ROA (TTM)18.71%3.37%
Net Margin (TTM)18.24%8.49%
Operating Margin (TTM)23.12%14.73%
Gross Margin (TTM)72.24%49.49%

Growth

Revenue Growth

Both Medpace (MEDP) at 19.97% and Dr. Reddy's Laboratories (RDY) at 3.19% land near their industries' usual revenue growth ranges, so top-line momentum looks broadly in line with peers on both sides.

Loading chart…
Medpace (MEDP) vs. Dr. Reddy's Laboratories (RDY): A comparison of their Revenue Growth across different time periods.

EPS Growth

Both Medpace (MEDP) at 20.98% and Dr. Reddy's Laboratories (RDY) at -24.14% land near their industries' usual EPS growth ranges, so bottom-line momentum looks broadly in line with peers on both sides.

Loading chart…
Medpace (MEDP) vs. Dr. Reddy's Laboratories (RDY): A comparison of their EPS Growth across different time periods.

Growth Metrics

Growth metrics for Medpace (MEDP) and Dr. Reddy's Laboratories (RDY)
MetricMEDPRDY
Revenue Growth (YoY)19.97%3.19%
Revenue Growth (3Y CAGR)20.12%10.96%
EPS Growth (YoY)20.98%-24.14%
EPS Growth (3Y CAGR)28.04%-1.72%

Financial Strength

Current Ratio (MRQ)

Both Medpace (MEDP) at 0.83 and Dr. Reddy's Laboratories (RDY) at 1.93 run current ratio in the tighter-liquidity quartile of industry peers, leaving thinner cushions against current liabilities than typical competitors.

MEDP

Pharmaceuticals, Biotechnology & Life Sciences industry group

0.83

Max
25.13
Q3
12.13
Median
5.52
Q1
2.47
MEDP
0.83
Min
0.10

RDY

Pharmaceuticals, Biotechnology & Life Sciences industry group

1.93

Max
25.13
Q3
12.13
Median
5.52
Q1
2.47
RDY
1.93
Min
0.10
Loading chart…
Medpace (MEDP) vs. Dr. Reddy's Laboratories (RDY): A comparison of their current ratio against the Pharmaceuticals, Biotechnology & Life Sciences industry group benchmark.

Debt / Equity (MRQ)

Both Medpace (MEDP) at 0.29 and Dr. Reddy's Laboratories (RDY) at 0.19 fund their balance sheets with roughly industry-typical debt-to-equity mixes.

MEDP

Pharmaceuticals, Biotechnology & Life Sciences industry group

0.29

Max
1.42
Q3
0.65
MEDP
0.29
Median
0.15
Q1
0.02
Min
0.00

RDY

Pharmaceuticals, Biotechnology & Life Sciences industry group

0.19

Max
1.42
Q3
0.65
RDY
0.19
Median
0.15
Q1
0.02
Min
0.00
Loading chart…
Medpace (MEDP) vs. Dr. Reddy's Laboratories (RDY): A comparison of their debt-to-equity ratio against the Pharmaceuticals, Biotechnology & Life Sciences industry group benchmark.

Financial Strength Metrics

Financial strength metrics for Medpace (MEDP) and Dr. Reddy's Laboratories (RDY)
MetricMEDPRDY
Current Ratio (MRQ)0.831.93
Debt / Equity (MRQ)0.290.19
Net Debt / EBITDA-0.84-0.08

Dividends

Dividend Yield (TTM)

Medpace (MEDP) pays no dividend (yield 0.00%) — it may be reinvesting, using buybacks, or simply not returning cash through dividends. Meanwhile Dr. Reddy's Laboratories (RDY) reports a yield of 55.06%, ranking against industry peers normally.

MEDP

Pharmaceuticals, Biotechnology & Life Sciences industry group

0.00%

MEDP
0.00%
Max
0.00%
Q3
0.00%
Median
0.00%
Q1
0.00%
Min
0.00%

RDY

Pharmaceuticals, Biotechnology & Life Sciences industry group

55.06%

RDY
55.06%
Max
0.00%
Q3
0.00%
Median
0.00%
Q1
0.00%
Min
0.00%
Loading chart…
Medpace (MEDP) vs. Dr. Reddy's Laboratories (RDY): A comparison of their dividend yield against the Pharmaceuticals, Biotechnology & Life Sciences industry group benchmark.

Dividend Payout Ratio (TTM)

Medpace (MEDP) pays no dividend (payout 0.00%) — it may be reinvesting, using buybacks, or simply not returning cash through dividends. Meanwhile Dr. Reddy's Laboratories (RDY) reports a payout of 22.72%, ranking against industry peers normally.

MEDP

Pharmaceuticals, Biotechnology & Life Sciences industry group

0.00%

MEDP
0.00%
Max
0.00%
Q3
0.00%
Median
0.00%
Q1
0.00%
Min
0.00%

RDY

Pharmaceuticals, Biotechnology & Life Sciences industry group

22.72%

RDY
22.72%
Max
0.00%
Q3
0.00%
Median
0.00%
Q1
0.00%
Min
0.00%
Loading chart…
Medpace (MEDP) vs. Dr. Reddy's Laboratories (RDY): A comparison of their payout ratio against the Pharmaceuticals, Biotechnology & Life Sciences industry group benchmark.

Dividend Metrics

Dividend metrics for Medpace (MEDP) and Dr. Reddy's Laboratories (RDY)
MetricMEDPRDY
Dividend Yield (TTM)0.00%55.06%
Dividend Payout Ratio (TTM)0.00%22.72%

Valuation

P/E Ratio (TTM)

Both Medpace (MEDP) at 36.26 and Dr. Reddy's Laboratories (RDY) at 41.42 land around their industries’ usual P/E ratio levels — neither is getting a clear earnings-multiple discount or premium versus peers.

MEDP

Pharmaceuticals, Biotechnology & Life Sciences industry group

36.26

Max
85.34
Q3
43.46
MEDP
36.26
Median
26.69
Q1
13.30
Min
0.07

RDY

Pharmaceuticals, Biotechnology & Life Sciences industry group

41.42

Max
85.34
Q3
43.46
RDY
41.42
Median
26.69
Q1
13.30
Min
0.07
Loading chart…
Medpace (MEDP) vs. Dr. Reddy's Laboratories (RDY): A comparison of their P/E ratio against the Pharmaceuticals, Biotechnology & Life Sciences industry group benchmark.

P/S Ratio (TTM)

Dr. Reddy's Laboratories (RDY) at 0.04 sits in the cheaper P/S ratio quartile while Medpace (MEDP) at 6.44 prices around its industry’s middle — RDY costs less per dollar of sales, though read it alongside growth and margins.

MEDP

Pharmaceuticals, Biotechnology & Life Sciences industry group

6.44

Max
58.18
Q3
25.77
Median
7.30
MEDP
6.44
Q1
3.01
Min
0.01

RDY

Pharmaceuticals, Biotechnology & Life Sciences industry group

0.04

Max
58.18
Q3
25.77
Median
7.30
Q1
3.01
RDY
0.04
Min
0.01
Loading chart…
Medpace (MEDP) vs. Dr. Reddy's Laboratories (RDY): A comparison of their P/S ratio against the Pharmaceuticals, Biotechnology & Life Sciences industry group benchmark.

P/B Ratio (MRQ)

Measured against book value, both Medpace (MEDP) at 31.23 and Dr. Reddy's Laboratories (RDY) at 18.16 look expensive — each P/B ratio sits above its industry’s benchmark range.

MEDP

Pharmaceuticals, Biotechnology & Life Sciences industry group

31.23

MEDP
31.23
Max
13.53
Q3
6.54
Median
3.25
Q1
1.69
Min
-5.59

RDY

Pharmaceuticals, Biotechnology & Life Sciences industry group

18.16

RDY
18.16
Max
13.53
Q3
6.54
Median
3.25
Q1
1.69
Min
-5.59
Loading chart…
Medpace (MEDP) vs. Dr. Reddy's Laboratories (RDY): A comparison of their P/B ratio against the Pharmaceuticals, Biotechnology & Life Sciences industry group benchmark.

Valuation Metrics

Valuation metrics for Medpace (MEDP) and Dr. Reddy's Laboratories (RDY)
MetricMEDPRDY
P/E Ratio (TTM)36.2641.42
P/S Ratio (TTM)6.440.04
P/B Ratio (MRQ)31.2318.16
Free Cash Flow Yield (TTM)2.72%-53.03%